📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer. (2020)

First Author: O'Cathail SM

Attributed to: Understanding how an MLH1 promoter polymorphism predisposes to colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cancergen.2020.08.006

PubMed Identifier: 32871287

Publication URI: http://europepmc.org/abstract/MED/32871287

Type: Journal Article/Review

Volume: 248-249

Parent Publication: Cancer genetics